The fight against melanoma just got a new weapon after a drug called Yervoy, or ipilimumab, was given FDA approval for late-stage metastatic melanoma. The approval is a win for Bristol-Myers Squibb Company…
Jon C. Ogg Earnings season may still be in force, but we are looking for the coming week’s top coming events that could have a large impact on shares on Monday and throughout the week. …
Dell’s (NASDAQ: DELL) margins rushed past expectations and shares moved higher (Reuters) Bernanke said a strong US recovery is essential to global economic health (Reuters) Lawmakers attacked regulators and banks on the…
Bristol-Myers Squibb (NYSE: BMY) will cut nearly 1,000 workers. That is on top of large rounds of firings in 2007 and 2008. The company gave an odd reason for the action.”The ultimate…
Reuters: Petrobras raised $70 billion in the largest stock offer in history. Reuters: There will likely be no tax cut before the election, according to Democrats Reuters: Obama asked the Chinese premier…
Reuters: Japan’s plan to intervene in yen trading has not moved the currency lower. Reuters: Oil dropped as investor moved away from risk Reuters: Hewlett-Packard (NYSE: HPQ) sued to keep Mark Hurd…
These are some of this Friday’s top analyst calls with upgrades, downgrades, and initiations seen in Wall Street research notes: American Eagle Outfitters, Inc. (NYSE: AEO) Raised to Buy at Jefferies. Bristol-Myers…
Today’s edition of the BioHealth Business Daily is going to be very cancer-dominated due to the American Society of Clinical Oncology (ASCO) 2010 meeting that started this last weekend. There are many…
We have several big movers on news this morning, and none appear to be based upon earnings. Stocks on the move are ArQule Inc. (NASDAQ: ARQL), BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), Bristol-Myers…
These are some of the major research calls we have seen from analysts in their upgrades, downgrades, and initiations so far this Monday: Amazon.com, Inc. (NASDAQ: AMZN) Raised to Conviction Buy List…
The pharmaceutical industry has found a growing source of sales–the prescription of medicines, primarily used by adults in the past, to children. A portion of the sharp increase in drugs used by…
A look at the “hardest working” major brands for 2009 shows that a number of them belong to companies which have done poorly and, in at least one case, may file Chapter…
Reuters: The Senate overcame opposition to allow jobless benefits to be extended. Reuters: China will hope to keep the value of the yuan steady. Reuters: JC Penney (JCP) will focus on exclusive…
There are twelve major pharmaceutical firms that dominate this industry worldwide. Their combined market value is over $1 trillion with total annual sales of over $500 billion. The firms have developed and marketed most…
Short sellers sharply increased their bets against two of America’s most widely followed stocks. Shares sold short in Citigroup (NYSE:C) rose 36% to 381 million. The short interest in Apple (NASDAQ:AAPL) |…
